Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1947 1
1949 1
1958 1
1964 1
1965 3
1966 1
1967 2
1968 2
1969 2
1970 2
1971 3
1972 2
1974 1
1975 4
1976 2
1977 5
1978 5
1979 2
1980 4
1981 9
1982 9
1983 9
1984 13
1985 14
1986 14
1987 14
1988 14
1989 19
1990 25
1991 16
1992 19
1993 10
1994 6
1995 11
1996 17
1997 10
1998 10
1999 10
2000 25
2001 33
2002 30
2003 32
2004 30
2005 27
2006 29
2007 31
2008 52
2009 57
2010 46
2011 56
2012 48
2013 67
2014 75
2015 65
2016 73
2017 86
2018 101
2019 90
2020 106
2021 97
2022 115
2023 91
2024 131
2025 128
2026 108

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,920 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Spontaneous Urticaria: A Review.
Kolkhir P, Bonnekoh H, Metz M, Maurer M. Kolkhir P, et al. JAMA. 2024 Nov 5;332(17):1464-1477. doi: 10.1001/jama.2024.15568. JAMA. 2024. PMID: 39325444 Review.
The 2022 international urticaria guideline recommends the monoclonal anti-IgE antibody omalizumab as second-line treatment for antihistamine-refractory chronic spontaneous urticaria. ...Second-generation H1 antihistamines are first-line …
The 2022 international urticaria guideline recommends the monoclonal anti-IgE antibody omalizumab as second-line treatment for …
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment.
Zuberbier T, Ensina LF, Giménez-Arnau A, Grattan C, Kocatürk E, Kulthanan K, Kolkhir P, Maurer M. Zuberbier T, et al. Lancet. 2024 Jul 27;404(10450):393-404. doi: 10.1016/S0140-6736(24)00852-3. Epub 2024 Jul 11. Lancet. 2024. PMID: 39004090 Free article. Review.
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with itchy wheals, angio-oedema, or both. ...This Therapeutics article focuses on the evidence for these novel drugs and their role in addressing an unmet need for persona …
Chronic urticaria is a common and debilitating mast cell-driven skin disease presenting with itchy wheals, angio-oedema, or bo …
Predictors of treatment response in chronic spontaneous urticaria.
Fok JS, Kolkhir P, Church MK, Maurer M. Fok JS, et al. Allergy. 2021 Oct;76(10):2965-2981. doi: 10.1111/all.14757. Epub 2021 Feb 27. Allergy. 2021. PMID: 33539587 Review.
The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the international guideline, entails treatment escalation from second-generation H(1) -antihistamines (sgAHs) to omalizumab and cyclosporine until complete response …
The current therapeutic algorithm for chronic spontaneous urticaria (CSU), endorsed by the international guideline, entails …
New insights into chronic inducible urticaria.
Muñoz M, Kiefer LA, Pereira MP, Bizjak M, Maurer M. Muñoz M, et al. Curr Allergy Asthma Rep. 2024 Aug;24(8):457-469. doi: 10.1007/s11882-024-01160-y. Epub 2024 Jul 19. Curr Allergy Asthma Rep. 2024. PMID: 39028396 Free PMC article. Review.
PURPOSE OF REVIEW: Chronic inducible urticaria (CIndU) is a group of long-persisting and challenging to manage diseases, characterized by recurrent wheals and angioedema induced by definite triggers. ...Promising emerging therapies currently assessed in chronic …
PURPOSE OF REVIEW: Chronic inducible urticaria (CIndU) is a group of long-persisting and challenging to manage diseases, chara …
Urticaria.
Kolkhir P, Giménez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Kolkhir P, et al. Nat Rev Dis Primers. 2022 Sep 15;8(1):61. doi: 10.1038/s41572-022-00389-z. Nat Rev Dis Primers. 2022. PMID: 36109590 Review.
Chronic urticaria (CU) is either spontaneous or inducible, lasts >6 weeks and persists for >1 year in most patients. ...Current urticaria treatment aims at complete response, with a stepwise approach using second-generation H1 antihistamines …
Chronic urticaria (CU) is either spontaneous or inducible, lasts >6 weeks and persists for >1 year in most patients. ... …
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.
Curto-Barredo L, Giménez-Arnau AM. Curto-Barredo L, et al. G Ital Dermatol Venereol. 2019 Aug;154(4):444-456. doi: 10.23736/S0392-0488.19.06274-6. Epub 2019 Feb 4. G Ital Dermatol Venereol. 2019. PMID: 30717573 Review.
The second-generation H1-antihistamines (sgAH) are the first-line symptomatic treatment of patients with chronic spontaneous urticaria (CSU). ...This revision examines the available literature for therapies used in chronic urticaria, incl …
The second-generation H1-antihistamines (sgAH) are the first-line symptomatic treatment of patients with chronic sponta …
Treatment of acute urticaria: A systematic review.
Badloe FMS, Grosber M, Ring J, Kortekaas Krohn I, Gutermuth J. Badloe FMS, et al. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2082-2092. doi: 10.1111/jdv.19904. Epub 2024 Feb 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38420865
There are only a few clinical trials which address the treatment of acute urticaria (AU). Especially, the added value of systemic corticosteroids to antihistamines is unclear in treatment of severe AU. ...Recent guidelines on urticaria treatm …
There are only a few clinical trials which address the treatment of acute urticaria (AU). Especially, the added value of syste …
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical Trial.
Giménez-Arnau A, Ferrucci S, Ben-Shoshan M, Mikol V, Lucats L, Sun I, Mannent L, Gereige J. Giménez-Arnau A, et al. JAMA Dermatol. 2025 Jul 1;161(7):679-687. doi: 10.1001/jamadermatol.2025.0733. JAMA Dermatol. 2025. PMID: 40266575 Free PMC article. Clinical Trial.
IMPORTANCE: Chronic spontaneous urticaria (CSU) is a skin disease driven mainly by the activation of cutaneous mast cells through various mechanisms. ...The trial participants included adults aged 18 to 80 years with moderate to severe CSU (weekly Urticaria A …
IMPORTANCE: Chronic spontaneous urticaria (CSU) is a skin disease driven mainly by the activation of cutaneous mast cells thro …
BTK signaling-a crucial link in the pathophysiology of chronic spontaneous urticaria.
Bernstein JA, Maurer M, Saini SS. Bernstein JA, et al. J Allergy Clin Immunol. 2024 May;153(5):1229-1240. doi: 10.1016/j.jaci.2023.12.008. Epub 2023 Dec 21. J Allergy Clin Immunol. 2024. PMID: 38141832 Free article. Review.
Chronic spontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with itchy wheals, angioedema, or both for more than 6 weeks. ...With phase 3 studies of remibrutinib ongoing, it is hoped that BTK inhibitors will present an effective, well-tolerat …
Chronic spontaneous urticaria (CSU) is an inflammatory skin disorder that manifests with itchy wheals, angioedema, or both for …
Managing Chronic Urticaria in Children: An Update.
Ensina LF, Brandão L, Netchiporouk E, Bem-Shoshan M. Ensina LF, et al. Curr Allergy Asthma Rep. 2025 Apr 7;25(1):21. doi: 10.1007/s11882-025-01202-z. Curr Allergy Asthma Rep. 2025. PMID: 40192928 Review.
PURPOSE OF REVIEW: To provide an update and new insights into the management of pediatric patients with chronic urticaria. RECENT FINDINGS: Chronic urticaria in children may be more prevalent than previously thought, with a high resolution rate within …
PURPOSE OF REVIEW: To provide an update and new insights into the management of pediatric patients with chronic urticaria. REC …
1,920 results